Study Details
A study of ASP4070 to confirm safety and immunological response in patients with pollen allergy
Clinicaltrials.gov ID
Astellas Study ID
4070-CL-0010
EudraCT ID
N/A
Condition
Cedar Pollen Allergy
Phase
Phase 1
Age
20 years - 64 years
Sex
Female & Male
Product
ASP4070
Type
Interventional
Trial Dates
Jun 2015 - Jul 2016
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
66
A Phase 1 Study of ASP4070 to Confirm the Safety and Immunological Response in Patients With Cedar Pollinosis When Administered as Intramuscular Vaccination and as Intradermal Vaccination
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study of ASP4070 to confirm safety and immunological response in patients with pollen allergy? Contact us by filling our your information to the right and we’ll respond to you.